At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treatment of Early-Stage Covid-19 With a Herbal Compound, Xagrotin
In Brief
A Phase 2 clinical trial evaluating Xagrotin for Covid19. Completed, enrolled 661 participants across 1 site.
Detailed Summary
This is an interventional, multi-center, randomized study. Adults with confirmed covid-19 disease not more than 10 days before enrollment date were recruited (n=361). Patients in same condition who had treated with standard of care were randomly assigned to the control group (n=178). The investigators analyzed the effect of a herbal compound, Xagrotin, and also investigated impact of different characteristics for instance gender, age, duration of disease, smoking habits and concomitant diseases on the outcome.
Study Details
Timeline
Interventions
A group of patients were treated with Xagrotin with or without standard of care, the control group received stadard of care